Literature DB >> 21212934

Difference in the biological effects of Clostridium difficile toxin B in proliferating and non-proliferating cells.

Marta Lica1, Florian Schulz, Ilona Schelle, Martin May, Ingo Just, Harald Genth.   

Abstract

Toxin A (TcdA) and toxin B (TcdB) from Clostridium difficile are the causative agents of the C. difficile-associated diarrhea (CDAD) and its severe form, the pseudomembranous colitis. TcdA and TcdB both glucosylate and thereby inactivate low molecular weight GTP-binding proteins of the Rho, Rac, and Cdc42 subfamilies. In cultured cell lines, TcdB induces actin re-organization and bi-nucleation ("cytopathic effects") and cell death ("cytotoxic effects"). In this study, the role of cell cycle progression in the cytopathic and the cytotoxic effects of TcdB is evaluated by a differential analysis of these effects in proliferating and non-proliferating cells. Density-synchronized murine fibroblasts and confluent HT29 colonocytes are exploited as cell culture models for non-proliferating cells. Cell death is analyzed in terms of a loss of cell viability, phosphatidylserine exposure, and DNA fragmentation. In proliferating cells, TcdB blocks cell proliferation and induces apoptotic cell death. In contrast, TcdB induces non-apoptotic cell death in non-proliferating cells. TcdB-induced cell rounding turns out to be independent of cell cycle progression. Cell cycle progression is an important determinant in the biological effects of TcdB. With respect to the pathology of CDAD, this study leads to the new hypothesis that necrotic cell death of terminally differentiated colonocytes and inhibition of epithelial renewal of the colon contribute to the pathogenesis of CDAD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212934     DOI: 10.1007/s00210-010-0595-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

Authors:  M Warny; A C Keates; S Keates; I Castagliuolo; J K Zacks; S Aboudola; A Qamar; C Pothoulakis; J T LaMont; C P Kelly
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells.

Authors:  Gerly A C Brito; Jun Fujji; Benedito A Carneiro-Filho; Aldo A M Lima; Tom Obrig; Richard L Guerrant
Journal:  J Infect Dis       Date:  2002-10-29       Impact factor: 5.226

3.  Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors--reinforcing the critical role of RhoA in cytokinesis.

Authors:  Stefanie C Huelsenbeck; Martin May; Gudula Schmidt; Harald Genth
Journal:  Cell Motil Cytoskeleton       Date:  2009-11

4.  Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1.

Authors:  Ismael Halabi-Cabezon; Johannes Huelsenbeck; Martin May; Markus Ladwein; Klemens Rottner; Ingo Just; Harald Genth
Journal:  FEBS Lett       Date:  2008-10-09       Impact factor: 4.124

5.  Monoglucosylation of RhoA at threonine 37 blocks cytosol-membrane cycling.

Authors:  H Genth; K Aktories; I Just
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

6.  Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.

Authors:  P Sehr; G Joseph; H Genth; I Just; E Pick; K Aktories
Journal:  Biochemistry       Date:  1998-04-14       Impact factor: 3.162

Review 7.  Clostridium difficile toxins: more than mere inhibitors of Rho proteins.

Authors:  Harald Genth; Stefanie C Dreger; Johannes Huelsenbeck; Ingo Just
Journal:  Int J Biochem Cell Biol       Date:  2008-01-05       Impact factor: 5.085

8.  Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells.

Authors:  Maen Qa'Dan; Matthew Ramsey; Jeremy Daniel; Lea M Spyres; Barbara Safiejko-Mroczka; William Ortiz-Leduc; Jimmy D Ballard
Journal:  Cell Microbiol       Date:  2002-07       Impact factor: 3.715

Review 9.  Clostridium difficile-associated disease: new challenges from an established pathogen.

Authors:  Rebecca H Sunenshine; L Clifford McDonald
Journal:  Cleve Clin J Med       Date:  2006-02       Impact factor: 2.321

10.  Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation.

Authors:  J C Mills; N L Stone; J Erhardt; R N Pittman
Journal:  J Cell Biol       Date:  1998-02-09       Impact factor: 10.539

View more
  15 in total

1.  Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.

Authors:  Christianne Maria Tinoco-Veras; Ana Angélica Q A Santos; Joice Stipursky; Marcelo Meloni; Ana Paula Bérgamo Araujo; Danielle Abreu Foschetti; Diana López-Ureña; Carlos Quesada-Gómez; Renata F C Leitão; Flávia Carvalho Alcantara Gomes; Gerly Anne de Castro Brito
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

2.  Clostridium difficile toxin A attenuates Wnt/β-catenin signaling in intestinal epithelial cells.

Authors:  Bruno Bezerra Lima; Bárbara Faria Fonseca; Nathália da Graça Amado; Débora Moreira Lima; Ronaldo Albuquerque Ribeiro; José Garcia Abreu; Gerly Anne de Castro Brito
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

3.  Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms.

Authors:  Nicole M Chumbler; Melissa A Farrow; Lynne A Lapierre; Jeffrey L Franklin; D Borden Lacy
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

4.  Clostridium difficile toxin B-induced colonic inflammation is mediated by the FOXO3/PPM1B pathway in fetal human colon epithelial cells.

Authors:  Qingqing Xu; Ying Li; Yuejuan Zheng; Yijian Chen; Xiaogang Xu; Minggui Wang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 5.  Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.

Authors:  Yongrong Zhang; Hanping Feng
Journal:  Pathog Dis       Date:  2016-04-04       Impact factor: 3.166

6.  Probiotics for the treatment of Clostridium difficile associated disease.

Authors:  Leo R Fitzpatrick
Journal:  World J Gastrointest Pathophysiol       Date:  2013-08-15

7.  Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism.

Authors:  Nicole M Chumbler; Melissa A Farrow; Lynne A Lapierre; Jeffrey L Franklin; David B Haslam; David Haslam; James R Goldenring; D Borden Lacy
Journal:  PLoS Pathog       Date:  2012-12-06       Impact factor: 6.823

8.  DXD motif-dependent and -independent effects of the chlamydia trachomatis cytotoxin CT166.

Authors:  Miriam Bothe; Pavel Dutow; Andreas Pich; Harald Genth; Andreas Klos
Journal:  Toxins (Basel)       Date:  2015-02-17       Impact factor: 4.546

9.  Effects of Clostridium difficile toxin A and B on human T lymphocyte migration.

Authors:  Dan Wu; Antony George Joyee; Saravanan Nandagopal; Marianela Lopez; Xiuli Ma; Jody Berry; Francis Lin
Journal:  Toxins (Basel)       Date:  2013-05-03       Impact factor: 4.546

10.  The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.

Authors:  Ashleigh Hansen; Laurie Alston; Sarah E Tulk; L Patrick Schenck; Michael E Grassie; Basmah F Alhassan; Arun Teja Veermalla; Samir Al-Bashir; Fernand-Pierre Gendron; Christophe Altier; Justin A MacDonald; Paul L Beck; Simon A Hirota
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.